7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      A G-quadruplex-binding macrodomain within the “SARS-unique domain” is essential for the activity of the SARS-coronavirus replication–transcription complex

      brief-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The multi-domain non-structural protein 3 of SARS-coronavirus is a component of the viral replication/transcription complex (RTC). Among other domains, it contains three sequentially arranged macrodomains: the X domain and subdomains SUD-N as well as SUD-M within the “SARS-unique domain”. The X domain was proposed to be an ADP-ribose-1”-phosphatase or a poly(ADP-ribose)-binding protein, whereas SUD-NM binds oligo(G)-nucleotides capable of forming G-quadruplexes. Here, we describe the application of a reverse genetic approach to assess the importance of these macrodomains for the activity of the SARS-CoV RTC. To this end, Renilla luciferase-encoding SARS-CoV replicons with selectively deleted macrodomains were constructed and their ability to modulate the RTC activity was examined. While the SUD-N and the X domains were found to be dispensable, the SUD-M domain was crucial for viral genome replication/transcription. Moreover, alanine replacement of charged amino-acid residues of the SUD-M domain, which are likely involved in G-quadruplex-binding, caused abrogation of RTC activity.

          Graphical abstract

          Highlights

          • A SARS-CoV replicon encoding Renilla luciferase as reporter protein is constructed.

          • The role of three macrodomains for the replication/transcription complex is analyzed.

          • In contrast to macrodomains X and SUD-N, SUD-M is found indispensable for replication.

          • Site-directed mutagenesis identifies charged SUD-M residues required for replication.

          • These residues have previously been shown to be involved in G-quadruplex binding.

          Related collections

          Most cited references26

          • Record: found
          • Abstract: found
          • Article: not found

          Characterization of a novel coronavirus associated with severe acute respiratory syndrome.

          P Rota (2003)
          In March 2003, a novel coronavirus (SARS-CoV) was discovered in association with cases of severe acute respiratory syndrome (SARS). The sequence of the complete genome of SARS-CoV was determined, and the initial characterization of the viral genome is presented in this report. The genome of SARS-CoV is 29,727 nucleotides in length and has 11 open reading frames, and its genome organization is similar to that of other coronaviruses. Phylogenetic analyses and sequence comparisons showed that SARS-CoV is not closely related to any of the previously characterized coronaviruses.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.

            A novel coronavirus has been identified as the causative agent of severe acute respiratory syndrome (SARS). The viral main proteinase (Mpro, also called 3CLpro), which controls the activities of the coronavirus replication complex, is an attractive target for therapy. We determined crystal structures for human coronavirus (strain 229E) Mpro and for an inhibitor complex of porcine coronavirus [transmissible gastroenteritis virus (TGEV)] Mpro, and we constructed a homology model for SARS coronavirus (SARS-CoV) Mpro. The structures reveal a remarkable degree of conservation of the substrate-binding sites, which is further supported by recombinant SARS-CoV Mpro-mediated cleavage of a TGEV Mpro substrate. Molecular modeling suggests that available rhinovirus 3Cpro inhibitors may be modified to make them useful for treating SARS.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses

              Highlights • We review the outbreak of severe acute respiratory syndrome (SARS) in 2002–2003 and antiviral treatment of patients. • We review efforts towards the rational design of anti-SARS therapeutics. • We present a comprehensive list of all available 3-dimensional structures of coronavirus proteins. • We discuss the emerging MERS coronavirus and review the few antivirals available for treatment. • We critically discuss which lessons have been learned from SARS and which are yet to be learned.
                Bookmark

                Author and article information

                Contributors
                Journal
                Virology
                Virology
                Virology
                Elsevier Inc.
                0042-6822
                1096-0341
                3 July 2015
                October 2015
                3 July 2015
                : 484
                : 313-322
                Affiliations
                [a ]Institute of Biochemistry, Center for Structural and Cell Biology in Medicine, University of Lübeck, Lübeck, Germany
                [b ]German Center for Infection Research (DZIF), Hamburg – Lübeck – Borstel Site, University of Lübeck, Germany
                [c ]Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Campus Universidad Autónoma, Madrid, Spain
                Author notes
                [1]

                Present address: Centro de Biología Molecular Severo Ochoa. Consejo Superior de Investigaciones Científicas. Universidad Autónoma de Madrid (CSIC-UAM). Nicolás Cabrera 1, 28049 Madrid, Spain.

                Article
                S0042-6822(15)00294-9
                10.1016/j.virol.2015.06.016
                4567502
                26149721
                e9d93f62-0d45-4b23-8a19-f13ceb685acd
                Copyright © 2015 Elsevier Inc. All rights reserved.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 1 March 2015
                : 19 March 2015
                : 12 June 2015
                Categories
                Article

                Microbiology & Virology
                sars-cov replicon,sars-unique domain,macrodomain,x-domain,reverse genetics,g-quadruplex,mers-cov

                Comments

                Comment on this article